References
- PorpodisKDomvriKZarogoulidisPRoflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patientsInt J Chron Obstruct Pulmon Dis2015101123112826109853
- PattersonCMMorrisonRLD’SouzaATengXSHappelKIInhaled fluticasone propionate impairs pulmonary clearance of Klebsiella pneumoniae in miceRespir Res20121314022651370
- TashkinDPFergusonGTCombination bronchodilator therapy in the management of chronic obstructive pulmonary diseaseRespir Res20131414923651244
- CalverleyPMRabeKFGoehringUMRoflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trialsLancet2009374969168569419716960
References
- AlmagroPSalvadoMGarcia-VidalCRecent improvement in long-term survival after a COPD hospitalisationThorax201065429830220388752
- KesslerRStahlEVogelmeierCPatient understanding, detection, and experience of COPD exacerbations: an observational, interview-based studyChest2006130113314216840393
- DecramerMCooperCBTreatment of COPD: the sooner the better?Thorax201065983784120805184
- DonaldsonGCHurstJRSmithCJHubbardRBWedzichaJAIncreased risk of myocardial infarction and stroke following exacerbation of COPDChest201013751091109720022970
- WedzichaJASeemungalTACOPD exacerbations: defining their cause and preventionLancet2007370958978679617765528
- Soler-CatalunaJJMartinez-GarciaMARoman SanchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622